Regulation of the human TRAIL gene

by Allen, Joshua E., El-Deiry, Wafik S.
Published 2012

Calcein-effluxing human colon cancer cells are enriched for self-renewal capacity and depend on β-catenin

by Allen, Joshua E., El-Deiry, Wafik S.
Published 2013

Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia

by Sinha, Indu, Allen, Joshua E, Pinto, John T, Sinha, Raghu
Published 2014

First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent

by Allen, Joshua E., Crowder, Roslyn, El-Deiry, Wafik S.
Published 2015

Correction: First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent

by Allen, Joshua E., Crowder, Roslyn N., El-Deiry, Wafik S.
Published 2016

Detection of circulating tumor cells in the cerebrospinal fluid of a patient with a solitary metastasis from breast cancer: A case report

by PATEL, AKSHAL S., ALLEN, JOSHUA E., DICKER, DAVID T., SHEEHAN, JONAS M., GLANTZ, MICHAEL J., EL-DEIRY, WAFIK S.
Published 2014

Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases

by Patel, Akshal S., Allen, Joshua E., Dicker, David T., Peters, Kristi L., Sheehan, Jonas M., Glantz, Michael J., El-Deiry, Wafik S.
Published 2011

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis

by Abdulghani, Junaid, Allen, Joshua E., Dicker, David T., Liu, Yingqiu Yvette, Goldenberg, David, Smith, Charles D., Humphreys, Robin, El-Deiry, Wafik S.
Published 2013

Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer

by Allen, Joshua E., Gallant, Jean-Nicolas, Dicker, David T., Amin, Shantu, Irby, Rosalyn B., Sharma, Arun K., El-Deiry, Wafik S.
Published 2013

The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer

by Allen, Joshua E., Gallant, Jean-Nicolas, Dicker, David T., Amin, Shantu, Irby, Rosalyn B., Sharma, Arun K., El-Deiry, Wafik S.
Published 2013

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

by Allen, Joshua E, Krigsfeld, Gabriel, Patel, Luv, Mayes, Patrick A, Dicker, David T, Wu, Gen Sheng, El-Deiry, Wafik S
Published 2015

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs

by Allen, Joshua E., Saroya, Bikramajit Singh, Kunkel, Miriam, Dicker, David T., Das, Avisnata, Peters, Kristi L., Joudeh, Jamal, Zhu, Junjia, El-Deiry, Wafik S.
Published 2013

The angular structure of ONC201, a TRAIL pathway-inducing compound, determines its potent anti-cancer activity

by Wagner, Jessica, Kline, Christina Leah, Pottorf, Richard S., Nallaganchu, Bhaskara Rao, Olson, Gary L., Dicker, David T., Allen, Joshua E., El-Deiry, Wafik S.
Published 2015

Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein

by McKee, Chad M., Ding, Yunchuan, Zhou, Jianfeng, Li, Chunrui, Huang, Liang, Xin, Xiangke, He, Jing, Allen, Joshua E., El-Deiry, Wafik S., Cao, Yunhong, Muschel, Ruth J., Xu, Danmei
Published 2015